Increasing rates of melanoma among nonwhites in Florida compared with the United States

Archives of Dermatology

Volumn 146, Issue 7, 2010, Pages 741-746

  Rouhani, Panta ^a   Pinheiro, Paulo S ^c   Sherman, Recinda ^a   Arheart, Kris ^a   Fleming, Lora E ^a   MacKinnon, J ^a   Kirsner, Robert S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HISPANIC; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RACE; STANDARDIZED INCIDENCE RATIO; TREND STUDY; UNITED STATES; CLINICAL TRIAL; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; INCIDENCE; MULTICENTER STUDY; PUBLIC HEALTH; REGISTER; RISK FACTOR; SKIN TUMOR; STATISTICS AND NUMERICAL DATA; TRENDS;

AFRICAN AMERICANS; FEMALE; FLORIDA; HISPANIC AMERICANS; HUMANS; INCIDENCE; MALE; MELANOMA; PUBLIC HEALTH; REGISTRIES; RISK FACTORS; SEER PROGRAM; SKIN NEOPLASMS; UNITED STATES;

EID: 77954826902     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.133     Document Type: Article

References (50)

1. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute, based on November 2006 SEER data submission, posted to the SEER Web site, 2007. http://seer.cancer.gov/csr/ 1975-2004/. Accessed October 6, 2007.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
3. World Health Organization. World Health report 2001 - Mental Health: New Understanding, New Hope. Geneva, Switzerland: World Health Organization; 2001.
4. Lucas RM, McMichael AJ, Armstrong BK, Smith WT. Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol. 2008;37(3):654-667.
5. Hu S, Ma F, Collado-Mesa F, Kirsner RS. UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Dermatol. 2004;140(7):819-824.
6. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations - US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. Arch Dermatol. 2005;141(4):477-481.
7. Krishnamurthy S. The geography of non-ocular malignant melanoma in India: its association with latitude, ozone levels and UV light exposure. Int J Cancer. 1992;51(2):169-172.
8. Pennello G, Devesa S, Gail M. Association of surface ultraviolet B radiation levels with melanoma and nonmelanoma skin cancer in United States blacks. Cancer Epidemiol Biomarkers Prev. 2000;9(3):291-297. (Pubitemid 30165442)
9. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88(1):15-19.
10. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California Cancer Registry data, 1988-93. Cancer Causes Control. 1997;8(2):246-252.
11. Hu S, Parker DF, Thomas AG, Kirsner RS. Advanced presentation of melanoma in African Americans: the Miami-Dade County experience. J Am Acad Dermatol. 2004;51(6):1031-1032.
12. Hu S, Soza-Vento RM, Parker DF, Kirsner RS. Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. Arch Dermatol. 2006;142(6):704-708.
13. Bellows CF, Belafsky P, Fortgang IS, Beech DJ. Melanoma in African-Americans: trends in biological behavior and clinical characteristics over two decades. J Surg Oncol. 2001;78(1):10-16.
14. American Cancer Society. Facts & Figures 2007. Atlanta, GA: American Cancer Society; 2007.
15. Kinney JP, Long CS. The Ultraviolet Index: a useful tool. Dermatol Online J. 2000;6(1):2.
16. US Census Bureau. Census 2000 Data for the State of Florida - General Demographic Characteristics. http://www.census.gov/census2000/states/fl.html. Updated 2003. Accessed April 5, 2008.
17. Surveillance, Epidemiology, and End Results (SEER) Program. Overview of the SEER Program. http://seer.cancer.gov/about/.html. Accessed April 6, 2008.
18. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276-1299.
19. Huang Y, Hylton T, Fan Z, Middaugh J. Florida Annual Cancer Report: 2003 Incidence and Mortality. Tallahassee: Florida Department of Health; 2007.
20. Jean-Baptiste R, Gebhard IK. Series IV: Cancer Case Ascertainment: Procedure Guidelines for Cancer Registries. Springfield, IL: North American Association of Central Cancer Registries; 2002.
21. Fritz A, Percy C, Jack A, Kanagaratnam S, Sobin L, Parkin DM. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
22. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database. Incidence - SEER 13 Regs Limited-Use, Nov 2006 Sub (1992-2004). Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2007, based on the November 2006 submission. Accessed January 12, 2010.
23. Surveillance, Epidemiology, and End Results (SEER) Program. Characteristics of the SEER population compared with the total United States population. http://www.seer.cancer.gov/registries/characteristics.html. Accessed April 3, 2008.
24. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol. 1997;50(8):939-945.
25. NAACCR Latino Research Work Group. NAACCR Guideline for Enhancing Hispanic/Latino Identification: Revised NAACCR Hispanic/Latino Identification Algorithm. Vol 2. Springfield, IL: North American Association of Central Cancer Registries; 2005.
26. Pinheiro PS, Sherman RL, Trapido EJ, et al. Cancer incidence in first generation US Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomarkers Prev. 2009;18(8):2162-2169.
27. Clegg LX, Reichman ME, Hankey BF, et al. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control. 2007;18(2):177-187.
28. Coronado GD, Koepsell TD, Thompson B, Schwartz SM, Wharton RS, Grossman JE. Assessing cervical cancer risk in Hispanics. Cancer Epidemiol Biomarkers Prev. 2002;11(10, pt 1):979-984.
29. Washington State Department of Health. Health of Washington State. Guidelines for Using Confidence Intervals for Public Health Assessment. Olympia: Washington State Department of Health. Updated 2002. http://www.doh.wa.gov/HWS/ HWS2007.htm. Accessed March 31, 2008.
30. Brillinger DR. The natural variability of vital rates and associated statistics. Biometrics. 1986;42(4):693-734.
31. SAS Institute Inc. SAS software version 9.1.3 . Cary, NC: SAS Institute Inc; 2000-2004.
32. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16(7):791-801.
33. Surveillance Research Program. SEER*Stat software version 6.3.6. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/seerstat. Accessed April 21, 2010.
34. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351.
35. National Cancer Institute. Joinpoint regression program version 3.2. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; January 2008.
36. Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166(17):1907-1914.
37. Crombie IK. Racial differences in melanoma incidence. Br J Cancer. 1979;40(2):185-193.
38. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93(9):678-683. (Pubitemid 32492808)
39. Streetly A, Markowe H. Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol. 1995;24(5):897-907. (Pubitemid 26434114)
40. Byrd KM, Wilson DC, Hoyler SS, Peck GL. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol. 2004;50(1):21-24, 142-143.
41. Byrd-Miles K, Toombs EL, Peck GL. Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians. J Drugs Dermatol. 2007;6(1):10-16.
42. Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741-760.
43. US Census Bureau. Census 2000 data for the State of California - general demographics characteristics. http://www.census.gov/census2000/states/ca.html. Updated 2003. Accessed April 5, 2008.
44. Parra EJ, Kittles RA, Shriver MD. Implications of correlations between skin color and genetic ancestry for biomedical research. Nat Genet. 2004;36(11)(suppl):S54-S60.
45. Parra EJ. Human pigmentation variation: evolution, genetic basis, and implications for public health. Am J Phys Anthropol. 2007;134(suppl 45):85-105.
46. Halder RM, Ara CJ. Skin cancer and photoaging in ethnic skin. Dermatol Clin. 2003;21(4):725-732.
47. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer. 1995;75(2)(suppl):667-673.
48. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40(8)(suppl):IV-19-IV-25.
49. Hofmann U, Szedlak M, Rittgen W, Jung EG, Schadendorf D. Primary staging and follow-up in melanoma patients - monocenter evaluation of methods, costs and patient survival. Br J Cancer. 2002;87(2):151-157.
50. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93.